Mather Group’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Hold
82
﹤0.01% 1458
2026
Q1
$10.6K Buy
+82
New +$11.8K ﹤0.01% 1441
2025
Q4
Sell
-82
Closed -$9.84K 1104
2025
Q3
$9.84K Buy
+82
New +$10.4K ﹤0.01% 1273
2025
Q2
Sell
-94
Closed -$13.1K 1119
2025
Q1
$13.1K Buy
94
+12
+15% +$1.86K ﹤0.01% 1191
2024
Q4
$12.7K Buy
82
+75
+1,071% +$12.7K ﹤0.01% 1184
2024
Q3
$1.28K Sell
7
-18
-72% -$2.67K ﹤0.01% 1535
2024
Q2
$2.68K Sell
25
-2
-7% -$210 ﹤0.01% 1809
2024
Q1
$2.69K Buy
+27
New +$2.69K ﹤0.01% 1488

Other funds holding ICUI

Mather Group's ICUI Position: Q2 2026 in Review

Mather Group held its ICU Medical (ICUI) position steady in Q2 2026 at 82 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Mather Group first reported a position in ICUI in Q1 2024 and has held it in 8 quarters since. The position peaked at $13.1K in Q1 2025. 289 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Mather Group held 82 shares of ICU Medical worth $12K as of Q2 2026.
  • Mather Group left its ICU Medical share count unchanged in Q2 2026.
  • ICU Medical made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1458 holding.
  • Mather Group first reported a position in ICU Medical in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's ICU Medical position peaked at $13.1K in Q1 2025.
  • 289 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.